DalsnaFinance › IPOs › BlossomHill Therapeutics › IPO
BlossomHill Therapeutics, Inc. completed its initial public offering on Nasdaq on August 4, 2026, pricing at $16.00 a share.
| Ticker | BLSM |
|---|---|
| Exchange | Nasdaq |
| Status | Completed |
| Listing date | August 4, 2026 |
| Offering price | $16.00 |
| Sector | Pharmaceutical Preparations |
BlossomHill Therapeutics, Inc. listed on Nasdaq on 2026-08-04.
Ingested from SEC EDGAR (424B4, 8-A12B), CIK 1839970.
BlossomHill Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for BlossomHill Therapeutics, Inc.. This page is general information, not investment advice.